Total Payments
$42,824
2024 Payments
$875.09
Companies
35
Transactions
879
Medicare Patients
1,275
Medicare Billing
$3.8M
Payment Breakdown by Category
Other$16,980 (39.7%)
Food & Beverage$14,299 (33.4%)
Consulting$7,333 (17.1%)
Travel$3,977 (9.3%)
Education$235.11 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $16,980 | 15 | 39.7% |
| Food and Beverage | $14,299 | 836 | 33.4% |
| Consulting Fee | $7,333 | 7 | 17.1% |
| Travel and Lodging | $3,977 | 16 | 9.3% |
| Education | $235.11 | 5 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $20,369 | 81 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $8,623 | 53 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $2,630 | 164 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $1,950 | 1 | $0 (2021) |
| Lundbeck LLC | $1,464 | 111 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,192 | 61 | $0 (2024) |
| Avanir Pharmaceuticals, Inc. | $885.07 | 73 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $818.74 | 43 | $0 (2024) |
| Johnson & Johnson Health Care Systems Inc. | $585.00 | 1 | $0 (2022) |
| Vanda Pharmaceuticals Inc. | $551.35 | 39 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $875.09 | 63 | Otsuka America Pharmaceutical, Inc. ($215.11) |
| 2023 | $1,133 | 78 | Otsuka America Pharmaceutical, Inc. ($455.10) |
| 2022 | $2,234 | 89 | Johnson & Johnson Health Care Systems Inc. ($585.00) |
| 2021 | $6,177 | 125 | Janssen Pharmaceuticals, Inc ($2,533) |
| 2020 | $4,029 | 83 | Allergan, Inc. ($1,467) |
| 2019 | $8,899 | 141 | Janssen Pharmaceuticals, Inc ($4,188) |
| 2018 | $14,027 | 157 | Allergan Inc. ($12,238) |
| 2017 | $5,450 | 143 | Allergan Inc. ($3,843) |
All Payment Transactions
879 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $5.71 | General |
| Category: Neurology | ||||||
| 12/17/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $3.33 | General |
| Category: Neurology | ||||||
| 12/17/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $3.33 | General |
| Category: Neurology | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $15.53 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/10/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $7.91 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/03/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.27 | General |
| Category: PSYCHIATRY | ||||||
| 11/26/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/19/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: Neuroscience | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $13.88 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/12/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $3.00 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/05/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: PSYCHIATRY | ||||||
| 10/29/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $25.65 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $27.36 | General |
| Category: PSYCHIATRY | ||||||
| 10/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Neuropsychiatry | ||||||
| 10/15/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $4.95 | General |
| Category: PSYCHIATRY | ||||||
| 10/15/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $1.93 | General |
| Category: PSYCHIATRY | ||||||
| 10/08/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: NEUROLOGY | ||||||
| 10/08/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $6.53 | General |
| Category: Psychology/Psychiatric | ||||||
| 09/17/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $6.78 | General |
| Category: PSYCHIATRY | ||||||
| 09/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $10.18 | General |
| Category: PSYCHIATRY | ||||||
| 09/10/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: CNS | ||||||
| 09/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 341 | 2,152 | $1.5M | $992,675 |
| 2022 | 7 | 350 | 2,218 | $1.5M | $1.0M |
| 2021 | 8 | 288 | 2,025 | $1.6M | $955,889 |
| 2020 | 10 | 296 | 3,124 | $1.3M | $830,857 |
Total Patients
1,275
Total Services
9,519
Medicare Billing
$3.8M
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G2083 | Office or other outpatient visit for the evaluation and management of an established patient that requires the supervision of a physician or other qualified health care professional and provision of greater than 56 mg esketamine nasal self-administration, | Office | 2023 | 30 | 972 | $1.3M | $890,968 | 70.5% |
| 90837 | Psychotherapy, 1 hour | Office | 2023 | 37 | 548 | $100,486 | $58,257 | 58.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 119 | 326 | $54,972 | $25,893 | 47.1% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 108 | 253 | $21,675 | $11,928 | 55.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 20 | 20 | $4,455 | $2,700 | 60.6% |
| 90791 | Psychiatric diagnostic evaluation | Office | 2023 | 13 | 13 | $2,828 | $1,588 | 56.2% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2023 | 14 | 20 | $2,182 | $1,341 | 61.5% |
| G2083 | Office or other outpatient visit for the evaluation and management of an established patient that requires the supervision of a physician or other qualified health care professional and provision of greater than 56 mg esketamine nasal self-administration, | Office | 2022 | 29 | 1,029 | $1.3M | $926,718 | 69.3% |
| 90837 | Psychotherapy, 1 hour | Office | 2022 | 43 | 506 | $85,080 | $55,768 | 65.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 111 | 267 | $38,696 | $22,426 | 58.0% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 104 | 239 | $19,016 | $12,363 | 65.0% |
| 90834 | Psychotherapy, 45 minutes | Office | 2022 | 13 | 127 | $17,832 | $9,666 | 54.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 33 | 33 | $7,345 | $4,932 | 67.1% |
| 90791 | Psychiatric diagnostic evaluation | Office | 2022 | 17 | 17 | $3,416 | $1,641 | 48.0% |
| G2083 | Office or other outpatient visit for the evaluation and management of an established patient that requires the supervision of a physician or other qualified health care professional and provision of greater than 56 mg esketamine nasal self-administration, | Office | 2021 | 28 | 857 | $1.1M | $842,949 | 75.8% |
| 90868 | Transcranial magnetic stimulation treatment (stimulates nerve cells in brain to improve symptoms of depression), subsequent delivery and management, per session | Office | 2021 | 18 | 382 | $368,080 | $45,663 | 12.4% |
| 90837 | Psychotherapy, 60 minutes | Office | 2021 | 20 | 298 | $48,781 | $33,352 | 68.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 92 | 236 | $32,225 | $19,240 | 59.7% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 79 | 182 | $13,810 | $8,682 | 62.9% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2021 | 23 | 41 | $3,831 | $2,729 | 71.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 16 | 16 | $3,103 | $2,421 | 78.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 12 | 13 | $2,645 | $853.12 | 32.3% |
| G2083 | Office or other outpatient visit for the evaluation and management of an established patient that requires the supervision of a physician or other qualified health care professional and provision of greater than 56 mg esketamine nasal self-administration, | Office | 2020 | 16 | 713 | $926,900 | $626,990 | 67.6% |
| 99355 | Prolonged office or other outpatient service each 30 minutes beyond first hour | Office | 2020 | 15 | 776 | $122,540 | $63,521 | 51.8% |
| 99354 | Prolonged office or other outpatient service first hour | Office | 2020 | 15 | 391 | $81,085 | $42,101 | 51.9% |
About Dr. Lynne Lyons, MD
Dr. Lynne Lyons, MD is a Psychiatry healthcare provider based in West Bloomfield, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780644880.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lynne Lyons, MD has received a total of $42,824 in payments from pharmaceutical and medical device companies, with $875.09 received in 2024. These payments were reported across 879 transactions from 35 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($16,980).
As a Medicare-enrolled provider, Lyons has provided services to 1,275 Medicare beneficiaries, totaling 9,519 services with total Medicare billing of $3.8M. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location West Bloomfield, MI
- Active Since 03/24/2006
- Last Updated 01/20/2023
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1780644880
Products in Payments
- VRAYLAR (Drug) $20,823
- SPRAVATO (Drug) $10,958
- REXULTI (Drug) $2,924
- NUEDEXTA (Drug) $953.85
- AUSTEDO (Drug) $942.66
- TRINTELLIX (Drug) $629.71
- CAPLYTA (Drug) $534.63
- LATUDA (Drug) $421.25
- Fanapt (Drug) $360.69
- Nuedexta (Drug) $348.95
- INGREZZA (Drug) $347.95
- Trintellix (Drug) $329.96
- BRINTELLIX (Drug) $320.20
- VYVANSE (Drug) $305.04
- ABILIFY MAINTENA (Drug) $220.80
- HETLIOZ (Drug) $190.66
- INVEGA SUSTENNA (Drug) $162.71
- Auvelity (Drug) $149.29
- LYBALVI (Drug) $146.00
- VNS - Symmetry (Device) $143.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in West Bloomfield
Theodore Ruza, Do Pc, DO PC
Psychiatry — Payments: $218,190
Psychiatry $218,190
Lisa Coram, Do, DO
Psychiatry — Payments: $5,507
Psychiatry $5,507
Seema Kumar, Md, MD
Psychiatry — Payments: $5,497
Psychiatry $5,497
Arlene Kevonian, Md, MD
Psychiatry — Payments: $1,076
Psychiatry $1,076
Linda Waldman, Md, MD
Psychiatry — Payments: $973.85
Psychiatry $973.85
Dr. Masroor Haq, Md, MD
Psychiatry — Payments: $930.64
Psychiatry $930.64